The Drug Eluting Stents Market is expected to record a 5% CAGR over the forecast period. Drug-eluting stents are semi-rigid tubular devices made of metal and coated with slow-release or eluting drugs that block cell proliferation. The introduction of drug-eluting stents (DES) further advances medical technology to a new standard.
A full report of Drug Eluting Stent Market available at https://www.orionmarketreports.com/drug-eluting-stent-market/55829/
Drug Eluting Stent Market Segmentation
By Coating
• Polymer Based Coating
• Biodegradable
• Non-Biodegradable
• Polymer Free Coating
• Microporous Surface
• Microstructured Surface
• Slotted Tubular Surface
• Nanoporous Surface
By Application
• Coronary Artery Disease
• Peripheral Artery Disease
By End User
• Hospitals
• Ambulatory Surgical Centers
• Others
Major Players
• Boston Scientific Corporation
• Terumo Corporation
• Abbott Laboratories
• Medtronic Plc
• Biotronik SE & Co. KG
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
